Stemming from the 2012/2013 BioInnovate Program, ProVerum Medical was established by Dr Conor Harkin to develop a novel, minimally invasive treatment for patients with symptomatic Benign Prostatic Hyperplasia (BPH), an enlargement of the prostate gland, causing difficulty with urination. In April 2018, ProVerum Medical announced that it had closed a $4.2 million seed investment with Atlantic Bridge University Fund leading the investment round, a round which also included HBAN Medtech Syndicate, Irrus Investments, Boole and Xenium Capital. The team continues its journey to develop the product in preparation for full commercialisation.
- Established: 2014
- Funding: €4.7 million
- Status: Towards Commercialisation
- Links:: ProVerum Medical closes $4.2M investment round